- Advertisement -

Animal-Free Protein and Enzyme Deal Expanded by Dyadic and Fermbox Bio

Dyadic Applied BioSolutions expanded its collaboration with Fermbox Bio, a biotech research & manufacturing company developing and delivering bio-based products through precision fermentation and...

Precise DNA Breaks by CRISPR-SpRYgests Improves DNA Engineering

Lead author Kathleen A. Christie, PhD, postdoctoral researcher at Harvard Medical School; research fellow at Massachusetts General Hospital. If you’ve ever spent time in a...

Is Targeted Protein Degradation the “Break” Neurology Needs?

Register Now Angela M. Cacace, PhD Chief Scientific OfficerArvinas View Bio ...

Uncountable expands specialty chemicals footprint with four new deals

Uncountable, a software company that develops AI platforms for end-to-end product development, today announced it has signed four new agreements with specialty chemicals organizations...

CAR T Cells Target Senescent Cells, Reduce Age-Related Declines in Mice

Researchers headed by a team at Cold Spring Harbor Laboratory (CSHL) have developed an anti-aging chimeric antigen receptor (CAR) T cell therapy targeting the...

Report provides guide to funding for coral reef restoration projects

UC Santa Cruz played a leading role in a multi-agency group working for the U.S. Coral Reef Task Force to provide guidance on the...

ADC Developmentfrom Concept to Clinic

Read Now Antibody-drug conjugates (ADCs) combine the specificity of monoclonal antibodies with the therapeutic activity of small molecule payloads, enabling targeted delivery...

Designing the Ecosystem for CGT Success

Read Now Preserving the Promise: Insights from The Cell Summit ’26 In July 2026, BioLife Solutions welcomed leaders from across the cell...

ADC Developmentfrom Concept to Clinic

Read Now Antibody-drug conjugates (ADCs) combine the specificity of monoclonal antibodies with the therapeutic activity of small molecule payloads, enabling targeted delivery...

Designing the Ecosystem for CGT Success

Read Now Preserving the Promise: Insights from The Cell Summit ’26 In July 2026, BioLife Solutions welcomed leaders from across the cell...

How Alzheimer’s Risk Gene APOE4 Disrupts Myelination

One of the main ways that the APOE4 gene variant—the biggest genetic risk factor for late onset Alzheimer’s disease—undermines brain circuit function is by...

more new items

ADC Developmentfrom Concept to Clinic

Read Now Antibody-drug conjugates (ADCs) combine the specificity of monoclonal antibodies with the therapeutic activity of small molecule payloads, enabling targeted delivery...

Designing the Ecosystem for CGT Success

Read Now Preserving the Promise: Insights from The Cell Summit ’26 In July 2026, BioLife Solutions welcomed leaders from across the cell...

How Alzheimer’s Risk Gene APOE4 Disrupts Myelination

One of the main ways that the APOE4 gene variant—the biggest genetic risk factor for late onset Alzheimer’s disease—undermines brain circuit function is by...